key: cord-0051361-pd04pufk
authors: Singh, Natesh; Villoutreix, Bruno O.
title: Demystifying the Molecular Basis of Pyrazoloquinolinones Recognition at the Extracellular α1+/β3- Interface of the GABA(A) Receptor by Molecular Modeling
date: 2020-09-11
journal: Front Pharmacol
DOI: 10.3389/fphar.2020.561834
sha: c62c1bf626650095e45c0f47c6f65fd43289c332
doc_id: 51361
cord_uid: pd04pufk

GABA(A) receptors are pentameric ligand-gated ion channels that serve as major inhibitory neurotransmitter receptors in the mammalian brain and the target of numerous clinically relevant drugs interacting with different ligand binding sites. Here, we report an in silico approach to investigate the binding of pyrazoloquinolinones (PQs) that mediate allosteric effects through the extracellular α+/β- interface of GABA(A) receptors. First, we docked a potent prototype of PQs into the α1+/β3- site of a homology model of the human α1β3γ2 subtype of the GABA(A) receptor. Next, for each docking pose, we computationally derived protein-ligand complexes for 18 PQ analogs with known experimental potency. Subsequently, binding energy was calculated for all complexes using the molecular mechanics-generalized Born surface area method. Finally, docking poses were quantitatively assessed in the light of experimental data to derive a binding hypothesis. Collectively, the results indicate that PQs at the α1+/β3- site likely exhibit a common binding mode that can be characterized by a hydrogen bond interaction with β3Q64 and hydrophobic interactions involving residues α1F99, β3Y62, β3M115, α1Y159, and α1Y209. Importantly, our results are in good agreement with the recently resolved cryo-Electron Microscopy structures of the human α1β3γ2 and α1β2γ2 subtypes of GABA(A) receptors.

The structural elucidation of a ligand-receptor complex lays the foundation for efficient lead optimization cycles. However, the structural resolution of a protein complex can be timeconsuming and very challenging, even more so for membrane proteins (Singh and Ecker, 2018; Scalise et al., 2020) . In the absence of protein structure information, different methods can be used to identify putative hit compounds. Two prominent approaches include (1) structure-based design using homology modeling and molecular docking (Schmidt et al., 2014; Louet et al., 2017; Palazzolo et al., 2018; Singh et al., 2019a; Singh et al., 2019b; Singh et al., 2020c) and (2) ligand-based modeling (Chaput et al., 2020) using the structure-activity relationships (Kubinyi, 1998) (SARs) information derived from experimentally validated compound libraries. Notably, homology modeling, in conjunction with molecular docking, is widely used in virtual screening (Spyrakis and Cavasotto, 2015; Slater and Kontoyianni, 2019; Singh et al., 2020b) . Investigating the possible ligand-binding modes facilitates hit-to-lead optimization and guides the rational design and synthesis of new chemical candidates with enhanced potency and selectivity for a target. Moreover, such knowledge can be taken into account to optimize the absorption, distribution, metabolism, and excretion (ADME) and toxicity parameters, such as solubility and metabolic stability, without disrupting essential ligand-receptor interactions (Greer et al., 1994; Maddaford, 2012) . Also, this information can assist in identifying molecular determinants leading, for instance, to the agonist and antagonist behaviors of the ligands (Warne et al., 2011) . However, studies have shown that docking programs are capable of reproducing the correct binding orientations, but the scoring functions often struggle to rank the correct orientations on top of the graded list (Siebert et al., 2018b) . Hence, there is a need to identify new protocols and scoring techniques that increase the reliability of the binding hypotheses by assessing the congruency between the predicted and experimental binding affinity of the compounds.

GABA A receptors are ligand-gated ion channels that serve as essential molecular targets for several important clinical drugs like benzodiazepines, barbiturates, neuroactive steroids, anesthetics, and anticonvulsants (Sieghart, 2015) . GABA A receptors in mammals represent a heterogeneous cluster of pentameric receptors compiled from a pool of 19 potential subunits (a1-6, b1-3, g1-3, d, ϵ, q, p, and r1-3) (Olsen and Sieghart, 2008) . In the brain, the majority of the GABA A receptors is composed of two a, two b, and one g subunits (Olsen and Sieghart, 2008) , and their arrangement can be described by topology b-a-g-b-a (Tretter et al., 1997) (Figure 1) , where each subunit interface, by convention, has a primary (+, plus) and a complementary (-, minus) side (Galzi and Changeux, 1994) . gaminobutyric acid (GABA) binds to the extracellular part of the receptor at the interfaces between the aand b+ subunits ( Figure 1A ). This leads to conformational changes that cause the channel to open and chloride anions to flow through (Jansen, 2019) . Benzodiazepines via binding to an allosteric site located at the extracellular a+/gsubunit interface mediate their anxiolytic, muscle-relaxant, sedative-hypnotic, and anticonvulsant effects (Sigel, 2002; Richter et al., 2012) ( Figure 1A ). Mutations affecting GABA A receptors have been shown to cause neurological disorders such as epilepsy (Jansen, 2019) .

The pyrazoloquinolinones (PQs) exhibit high potential as both non-sedative anxiolytics and as benzodiazepine antagonists (Savini et al., 2001; Vega Alanis et al., 2020) and, as such, represent interesting chemotypes. PQs exhibit features of both "continuous" and "discontinuous" SARs, depending on the corresponding substitution sites over the scaffold. A continuous SAR is described by a smooth activity hypersurface, where a clear trend in experimental activity could be detected upon systematic chemical changes, whereas a discontinuous SAR, in contrast, is depicted by a rugged landscape where slight structural modifications lead to drastic potency differences (Cruz-Monteagudo et al., 2014; Siebert et al., 2018b) . Recent studies have demonstrated that in many subtypes of abg receptors, PQs exerts positive modulatory effects via an alternate allosteric binding site at the homologous a+/b-interface (Figures 1A, D) (Ramerstorfer et al., 2011) . In contrast, the effects are antagonistic, i.e., flumazenil-like (Varagic et al., 2013a; Varagic et al., 2013b) , when they bind at the high-affinity benzodiazepine site (a+/g-) in most subtypes. Since a combined aand bisoform selectivity can be achieved, and binding is independent of additional subunits such as g or d, the a+/binterface binding site is a potentially very attractive target for novel chemical probes (Simeone et al., 2017) . Structural hypotheses of bound states would be helpful in developing more potent and possibly subtype-selective ligands. Recently, our colleagues elucidated the PQ binding mode at the benzodiazepine site (Siebert et al., 2018b ) via a novel structurebased approach by utilizing ligand-based knowledge to frame a docking scoring function that assessed ligand binding poses for their congruency to recognized PQ-SAR. The important feature of this scoring scheme is the post-docking derivatization technique. This tool generates a congeneric series of proteinligand complexes from the given set of docking poses through substituent placements, which can be used for rescoring (Zhenin et al., 2018; Rastelli and Pinzi, 2019; Singh et al., 2020a) and SAR congruency assessment.

We hypothesize that the PQs exhibit a common binding mode at the a+/bsite and that the correct orientation should be able to explain the inherent bioactivity trend and the experimental mutagenesis findings. Given the challenges associated with molecular docking and the concurrent availability of SAR data for PQs (Savini et al., 2001) , we applied in this study, a structure-based protocol outlined in Figure 2 . This approach integrates the ligand bioactivity information during the assessment process of the docking poses so as to define a binding hypothesis for PQs binding at the a1+/b3interface. In the first step, a highly potent PQ, which has been extensively studied in multiple GABA A subtypes, was docked into the a1+/b3site of a homology model of the human a1b3g2 subtype of the GABA A receptor. This was followed by a pose expansion stage where we generated the proteinligand complexes of 18 other PQ analogs from the recovered docking solutions by using a post-docking derivatization method. Subsequently, geometry minimization was performed, and binding A B D C FIGURE 1 | (A) A graphical depiction of the extracellular domain (ECD) of the GABA A receptor. The different binding sites are indicated: the GABA binding site 'GABA', the high-affinity benzodiazepine binding site 'Bz', and the low-affinity 'CGS' site. (B) front view of the cryo-electron microscopy (cryo-EM) structure of the human a1b2g2 GABA A receptor (PDB ID: 6D6U). (C) The perpendicular top view of the structure. (D) Front view of the CGS site or a1+/b2interface, which is characterized by the presence of loops A-C and D-G in the a1+ and b2subunit, respectively. The a1, b3 and g2 subunits are depicted in ribbon style and are colored yellow, red, and blue, respectively. (B-D) were prepared using PyMOL v. 1.8.6.2 (DeLano, 2008. Available at: https://www.pymol.org," n.d.).

a1b3 GABA A Receptor-Pyrazoloquinolinones Binding Hypothesis

Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 561834 affinity was estimated for all complexes using molecular mechanicsgeneralized Born surface area (MM-GBSA) approach (Genheden and Ryde, 2015) ( Figure 2 ). The minimized complexes were then quantitatively evaluated by taking into consideration the experimental data through linear correlation calculations and then ranking the poses according to the SAR congruency score to determine the PQ top-ranked poses. Selected poses were optimized to investigate the previously reported 40-fold increase in potency of PQ 'CGS-9895' in the a1b3Q64A mutant (Siebert et al., 2018a) . Finally, the results from the modeling and docking studies were compared with the newly solved cryo-Electron Microscopy (cryo-EM) structures of the human a1b2g2 (PDB IDs: 6D6U, 6D6T) (Zhu et al., 2018) and the a1b3g2 (PDB IDs: 6HUG, 6HUJ, 6HUK, 6HUO, 6HUP, 6I53) Masiulis et al., 2019) subtypes of GABA A receptors. To the best of our knowledge, this is the first structure-based study devoted to the understanding of the a1b3 mediated ligand recognition, and the reported findings may facilitate the rational design and development of novel and selective chemical modulators of the a1b3 subunit interface.

At the time, when this study was started, the only GABA A receptor structure that was available was a partial b3subunit homopentamer (PDB ID: 4COF) (Miller and Aricescu, 2014) . This structure was therefore used as a template for generating the structural models of the a1b3g2 subtype using MODELLER (Sali and Blundell, 1993) . The constructed models were assessed on the basis of normalized discrete optimized protein energy (z-DOPE) score. The top-ranked model had a DOPE score of -0.98, suggesting that approximately greater than 80% of its Ca atoms are predicted to be within 3.5 Å of their accurate positions (Eramian et al., 2008, p. 1) , thus indicating a native-like structure ( Figure 3 and Figure S1 ). The overall quality of the model was then evaluated further using a Ramachandran plot after performing energy minimization with backbone atoms constrained. The PROCHECK (Laskowski et al., 1993; Laskowski et al., 2018) statistics showed that 94.4, 5.3, 0.3, and 0% of the residues, respectively, allocated as the "most favored," "additionally allowed," "generously allowed," and "disallowed" regions ( Figure S2 ). None of the residues located in generously or additionally allowed areas were in close proximity to the ligand-binding site. The model was also analyzed using the Profile-3D verify score (Eisenberg et al., 1997) , which measures the compatibility score of each residue in the given 3D environment. The model returned a verify score of 676.33 that was close to the expected high score of 761.126, while the expected low score was 342.50. Models with a verify score between the reference values are considered sub-optimal and require refinement, while models with a value closer to the expected high score are likely to be correct. If the overall quality is lower than the expected low score, then the structure is almost certainly misfolded (Eisenberg et al., 1997) . The model was lastly evaluated by measuring the root mean square deviation (RMSD) between its backbone atoms and those of the 4COF structure. The RMSD (0.33 Å) is very low, indicating further that the amino acids of the a1b3g2 subtype can adequately accommodate in the template 3D structure ( Figure S3 ). Overall, the structural analysis strongly indicates that the homology model of the a1b3g2 subtype is accurate and can be used for docking studies.

While writing this manuscript, several cryo-EM resolved heteropentameric structures of the human a1b2g2 and a1b3g2 subtypes of GABA A receptors became available. These data allowed us to perform a post-hoc validation of the homology model, in which we carried out the docking simulations. The analysis of two homologous binding sites (a1+/b3-and a1+/g2-) revealed that the hydrophobic residues g2Y58 and g2A79 at the a1+/g2interface are replaced by polar residues b2D43 and b2Q64 at the a1+/b3interface. While the charged residue g2D56 and the polar residue g2T142 at the a1+/g2interface corresponds to polar b3N41 and hydrophobic b3G127 at the a1+/b3interface ( Figure 4) . However, the active site residues belonging to the a1+ subunit are conserved at both interfaces, possibly indicating a similar a1 mediated interaction of the ligands. The backbone RMSD of the ECD between the two structures was 1.31 Å signifying the reliability of the homology model of the a1b3g2 subtype. Whereas the Ca RMSD value for the residues enclosing the a1+/b3and a1+/g2pocket was 0.95 Å indicating structurally similar ligand-binding sites. We also superposed the modeled a1+/b3site with the corresponding site of the new a1b3g2 structure (PDB ID: 6HUJ) . The alignment of the pockets displayed a low backbone RMSD of 1.6 Å ( Figure 5) , and it revealed similar binding orientation of the side chains of the residues emphasizing the high topological resemblance between the homology model and the experimental structure. The alignment showed that all the residues comprising the binding site in the homology model are identical to the cryo-EM structure, suggesting further that our homology model is accurate and appropriate for the docking studies. Next, we analyzed the binding site properties of a1+/b3interface using SiteMap v3.4 (Schrödinger Release 2015-1, 2015c) (see Methods). The a1+/b3site yielded a SiteScore of 1.11, a showing the a1+/g2interface (B). The non-conserved residues b3N41, b3D43, b3Y62, b3Q64, and b3G127 on the b3-subunit and the corresponding beta residues g2D56, g2Y58, g2A79, and g2T142 are highlighted indicating the pocket differences. The a1, b3 and g2 subunits are depicted in ribbon style and are colored yellow, red, and blue, respectively. The binding site residues are shown in stick style, and its carbon atoms are colored according to subunit. Dscore of 1.15, a volume of ∼335 Å 3 , and a total solvent accessible surface area of 752.25 Å 2 . The binding interface consists of 12.5% hydrophobic region, 54.5% hydrophilic region, and 33% mixed character region ( Figure S4 ). The hydrophilic zone is partitioned into hydrogen bond donor and acceptor regions. The hydrogen bond donor region accounts for 52% of the hydrophilic region and the hydrogen bond acceptor region, 48% of the hydrophilic region. The hydrogen bond acceptor and donor regions refer to the degree that a well-structured ligand could interact with hydrogen bond donor and acceptor residues, respectively. The hydrophobic region contains residues like b3A45, b3Y62, a1F99, b3M115, b3L125, b3G127, b3L128, a1G157, a1Y159, a1V202, a1Y209, a1V210, and a1V211, whereas the hydrophilic region contains residues like b3D43, b3N41, b3Q64, a1H101, a1K155, a1S158, b3R169, b3T176, b3R180, a1S204, a1S205, and a1T206. Importantly, the recent structure (6HUJ) also exhibited similar binding site characteristics and returned a SiteScore and Dscore > 1, where a score higher than 1 (Halgren, 2009) suggests good druggability, yet again indicating the trustworthiness of the homology model and its appropriateness for structure-based investigations.

PQ Dataset and Structure-Activity Relationship (SAR) Table 1 shows the experimentally measured data of PQs at the a1+/b3and the a1+/g2interface retrieved from the scientific literature (Varagic et al., 2013b) . For our protocol, we filtered those PQ compounds with reported pEC 50 values against the a1+/b3interface with the exception of meta-substituted (R ' 3 ) analogs ( Table 1) to preserve the homogeneity of the data set. A QSAR FIGURE 5 | The a1+/b3ligand-binding interface of the homology model (red) superposed to the corresponding site of the cryo-EM structure of a1b3g2 GABA A receptor (blue, PDB ID: 6HUJ). The Ca atoms and the side chains are shown in space-filling and stick style, respectively. The backbone RMSD between the two structures is 1.6 Å, and the alignment score is 0.1 suggesting good agreement with the experimental structure. study on the reported dataset revealed that lipophilic substituents at position R 8 (ring A), as well as electron-withdrawing moieties at the R' 4 position (ring D), are favorable for a1+/b3potency. This is reflected by the substitution pattern found in analogs 16, 17, and 19. Interestingly, in the a1g2 PQ-SAR (Savini et al., 2001) , the opposite is observed where electron-withdrawing groups dramatically reduce the potency. It seems that ring D in a1b3 is pointing toward an entirely different region than in a1g2. The PQ data set has much higher variability in the R ' 4 position (nine diverse substitutions) than at the R 8 position. At the R 8 position, small hydrophobic moieties, noticeably chlorine atom, are favorable for affinity in a1b3 as compared to bulky substituents such as tert-butyl, indicating some steric hindrance at this position. Whereas, in a1g2, the bulky substitutions are well tolerated at the R 8 position. In a1g2, the substitutions at the R 6 position are sterically disallowed, and any substitution leads to a dramatic loss in affinity (Siebert et al., 2018b) . Whereas the large tert-butyl substituent on position R 6 (7) is tolerated at the a1+/b3site. For a majority of the listed PQ analogs (Table 1) , experimental data for the a1+/g2site is available (compounds 1-14, 16, and 18). On average, the analogs exhibit four log units higher potency at the a1+/g2versus the a1+/b3site. Next to this overall trend, we analyzed the relative potency change (Da1b3 and Da1g2 in Table 1 ) of the analogs compared to the unsubstituted PQ scaffold (1) to assess substituent effects. In this analysis, the largest relative potency difference between the two binding sites was found for 7, 12, and 16.

In this study, we applied a docking-based strategy that incorporates experimental activity data, as described in Table  1 , to identify a common binding mode for PQs at the a1+/b3interface. As a first step toward identifying a binding hypothesis, a potent ligand 'PZ-II-028' (14 , Table 1 ) was docked into the a1+/b3pocket. Since compound 14 has been extensively studied in different GABA A receptor subtypes, and a large amount of experimental data is available for this ligand (Olsen and Sieghart, 2008; Varagic et al., 2013a; Varagic et al., 2013b; Mirheydari et al., 2014; Simeone et al., 2017; Treven et al., 2018) ; hence, this ligand serves as an excellent prototype (or reference ligand) for performing the docking studies. Molecular docking was performed using GOLD (Verdonk et al., 2003) with the flexible side chains option (see Methods). The distribution of 100 docking poses of compound 14 at the a1+/b3is shown in Figure S5 . To determine which molecular features are most relevant for binding, we performed structural interaction fingerprint (SIFt) (Deng et al., 2004; Singh et al., 2006) analysis of the docking poses of compound 14 using the cheminformatics utility of Schrödinger. This tool identifies the amino acid residues that show hydrogen bond or hydrophobic interactions with the docking poses. The SIFt analysis revealed that the docking poses were interacting with the amino acid residues of both a1+ and b3subunits, situated throughout the pocket. The major residues involved in hydrogen bond interactions include a1Y159, a1S204, a1S205, b3N41, and b3Q64, whereas the residues a1Y209 and b3Y62 stimulated the binding through hydrophobic interactions ( Figure S6 ).

Given the difficulties of scoring functions to correctly rank the ligands and to improve the quality of the poses obtained from docking into our homology model, we defined a scoring scheme that evaluates a1+/b3-PQ docking poses for its agreement with known PQ-SAR data. The scoring scheme for evaluating the 100 PZ-II-028 (p1-p100) poses consists of three steps: (i) analogs pose expansion using post-docking derivatization tool, (ii) energy minimization and binding energy calculations of the derivatized protein-ligand complexes, and (iii) SAR congruency assessment (i.e., calculation of correlation coefficient between the MM-GBSA scores and experimental data) and ranking of the poses according to the scores (see also Figure 2 ). The first preparatory step utilizes the previously published post-docking derivation tool (Siebert et al., 2018b) that results in the generation of the poses of related analogs (or 'analog expansion'). Here, based on the 3D coordinates of every PZ-II-028 docking pose, an array of 18 ligand-receptor complexes for analogs 1-13, and 15-19 (Table 1) is derived by adding substituents to the PQ scaffold of each docking pose of 14. This step expanded the total protein-ligand binding poses to 1900 at the a1+/b3from the first 100 docking poses of 14. In the second step, the binding energy of all 1900 protein-ligand complexes was calculated by using the Prime MM-GBSA method implemented in Schrödinger. Briefly, this method utilizes the VSGB 2.0 implicit solvation model (Li et al., 2011) and OPLS-2005 force field (Banks et al., 2005) for the optimization of pose geometries and interactions (see Methods). The optimization step allowed to eliminate any potential ligand strain or steric clashes of the ligand atoms with the protein residues that might have developed after post-docking derivatization or due to the use of soft potentials while docking. In addition to the calculation of the MM-GBSA energy values, we also recorded the RMSD deviation of the PQ scaffold before and after the geometric optimization. In summary, the output of the analog expansion step is a set of 18 new energy-minimized ligandreceptor geometries and their corresponding MM-GBSA energy values and RMSD deviations.

To assess the congruency of a PZ-II-028 docking pose and the resulting analog poses with existing experimental PQ SAR, we calculated the Pearson correlation coefficient between the predicted binding free energy (MM-GBSA) values of the "expanded analog set" and the corresponding bioactivity data (Table 1) . Here, we refer to the correlation coefficient as the SAR congruency coefficient (R SAR ) of a given docking pose. We calculated the R SAR for the entire pose library (p1-p100) ( Figure S7 ). To determine the most promising poses, we examined a scree plot (i.e., line plot) based on the R SAR values ( Figure 6A ) and identified four poses, p53, p66, p60, and p56, that showed R SAR of -0.83, -0.79, -0.75, and -0.72 and r 2 of 0.68, 0.62, 0.57, and 0.51, respectively ( Figure 4A) . The Leave-one-out (LOO) cross-validation q 2 follows the same trend as that of r 2 e.g., p53 (0.60) < p66 (0.51) < p60 (0.47) < p56 (0.38) ( Table 2 ). In addition, we performed Y-scrambling tests on these four docking poses (Rücker et al., 2007) using the QSPR/QSAR (Quantitative structure-property/activity relationship) "DEMOVA" package in R ["R Core Team (2018). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available online at https:// www.R-project.org/.," n.d.]. To this aim, we shuffled the bioactivity values of the PQ dataset and calculated the r 2 yscr and the LOO q 2 yscr . We obtained r 2 ysc and q 2 yscr values around 0 (P < 0.001) in all Yscrambling experiments that were performed. Therefore, these results indicate that the statistical metrics obtained from SAR congruency calculations of the docking poses are not a consequence of spurious correlations. Despite the high RMSD among the top-ranked poses (> 2 Å) (Table S1), they can be broadly grouped into two geometrically different binding modes, BM I (p53 and p56) ( Figure 7A ) and BM II (p66 and p60) ( Figure  7B ) depending upon the orientation of the PQ ring. In BM I, the PQ ring is oriented in a manner such that the R 8 substituent and the quinoline nitrogen is pointing toward the a1+ and b3subunits, respectively, while in BM II the R 8 substituent and the quinoline nitrogen (N5) are directed toward the b3and a1+ subunit. The quantitative characteristics of the BM I and BM II poses obtained from the SAR congruency assessment and RMSD evaluations are shown in Table 2 . While the regression plots between the predicted binding energy and pEC 50 of PQs for the four poses are shown in Figure S8 . Next, we utilized this R SAR metric to visualize the geometrical variability of the 100 optimized reference poses of compound 14 from a global perspective by performing classical multidimensional scaling (MDS). The RMSD matrix of the 100 optimized poses of compound 14 representing high-dimensional conformational space or geometric heterogeneity served as an input for performing the dimensional reduction. The low-dimensional representation provides a meaningful description of the global pose space and enables the identification of docking poses that share a similar binding orientation. Figure 6B shows the MDS projection of the optimized poses for molecule 14 in the R SAR landscape. Docking poses that are in close vicinity to each other share a similar binding orientation, whereas conformationally distinct or dissimilar poses are positioned distantly to each other. The MDS calculations further corroborate the geometric diversity among the top-ranked poses, which can be seen positioned distantly to each other in the plot. However, some less favorable poses are seen clustered near p56 and p66 that share similar binding orientation with low RMSD (<2 Å). TABLE 2 | Quantitative attributes of the top-ranked docking poses (p53, p66, p60, and p56) in terms of R SAR score, root mean square error (RMSE), r 2 , leave-one-out (LOO) cross-validation q 2 , Y-scrambling r 2 yscr , Y-scrambling q 2 yscr , and RMSD's with respect to the starting geometry. The important limitation of the MDS in understanding pose diversity is that it fails to account for the binding characteristics of the poses that play an essential role in pose categorization and deciphering the crucial protein-ligand contacts. Overall, p53 (BM I) and p66 (BM II) were the two representative binding orientations of PQs identified from the R SAR computations. Whereas p60 and p56 are of less interest due to their weak correlation with the PQ-SAR trend, and thus they were excluded from further analysis.

The visual inspection of the best performing BM I pose, p53 for the PQ 14 revealed that the aromatic pyrazoloquinoline scaffold is deeply buried in a sub-pocket formed by hydrophobic and aromatic residues (a1F99, a1H101, a1V202, a1Y209, and b3Y62) (Figures 7A and 8A) . In this pose, we observed major hydrophobic interactions of the fused ring system with the residues a1Y209 and/or b3Y62. Also, PQ is engaged in favorable van der Waals contacts with the protein residues a1Y159, a1F99, and b3M115. In contrast to the favorable orientation of the pyrazoloquinoline ring, the pending phenyl moiety (ring D) is only poorly bound, positioned unfavorably close to the acidic residue b3D43, and exposed to the solvent. This orientation of the rings is consistent with the observation of Varagic et al. (2013b) who proposed that upon binding, the ring D and the R 4 ' substituent of PQ are located in a hydrophilic environment, whereas the R 8 substituent extends into a hydrophobic pocket. Besides the hydrophobic interactions, PQ is engaged in electrostatic interactions as well. The methoxy group at the R ' 4 position of the phenyl ring is donating a hydrogen bond to the residue b3R180, while the carbonyl group is accepting a hydrogen bond from b3Q64. The quinolone and pyrazole nitrogens are not engaged in any polar contacts. Docking pose p53, in addition, supports the SAR trend where the presence of strong deactivating groups at the R' 4 position in highly active PQs (pEC 50 > 6) such as 16, 17, and 19 seems to reduce the electron density over the pending phenyl ring, thus alleviating the unfavorable electrostatic interaction with b3D43 and eventually resulting in potency gain. While the activating effects of the amino group at the R' 4 position in 18 seem to be compensated through a strong hydrogen bond interaction with the side chain of b3T176 ( Figure S9 ) that might explain its high potency. The low activities of PQs 1-6 (pEC 50 between 4 and 5) can be attributed to the lack of lipophilic substituent at the R 8 position that allows for favorable interactions with the hydrophobic subpocket. However, PQ 5 is comparatively better than the other members owing to the presence of a hydrophobic tert-butyl group at the R 8 position. The PQs 7-15 are moderately active (pEC 50 between 5 and 6), and maximum members of this group, except 7 and 10, have a lipophilic moiety attached at the R 8 position, which is engaged in hydrophobic interactions involving a1H101, a1V202, and a1Y209. These findings are consistent with those of Varagic and coworkers who showed that the electron-withdrawing substituents on rings A and D, as well as lipophilic R 8 and hydrophilic R 4 ' substituents, are beneficial for high potency (Varagic et al., 2013b) . Interestingly, the favorable effect of electron-withdrawing moieties at the R' 4 position in a1+/b3- (Varagic et al., 2013b) is inverted in the a1 +/g2-site (Savini et al., 2001) . The two outliers of p53 with the poorest prediction (i.e., showing high residuals) were the PQs 11 and 18. Removing these two PQs from the dataset and re-assessing the SAR congruency increased the R SAR score from 0.83 to 0.9 and r 2 from 0.68 to 0.79 ( Figure S10 ). This improvement in results further indicates that p53 can very well explain the variation in the bioactivity of the PQs. In BM II (p66) (Figures 7B and 8B ) the pyrazoloquinolinone scaffold is flipped by~180°with respect to BM I, resulting in an orientation where the chlorine atom at the R 8 position and the quinoline nitrogen are directed toward the b3and a1+ subunit, respectively. Likewise to BM I, the hydrophobic pending phenyl ring is positioned unfavorably close to the acidic residue b3D43. In contrast to BM I, no hydrogen bond interactions between 14 and the receptor were observed. The protein-ligand contacts of the poses are enumerated in Table 3 .

Recently, our coworkers elucidated the binding mode of PQ at the high affinity a1+/g2site ( Figure 8C) . Interestingly, A B FIGURE 7 | Best-predicted docking poses for compound 14 in a1b3. p53 (green) and p56 (violet) roughly corresponds to BM I (A), while p60 (green) and p66 (violet) correspond to BM II (B). In the figures, the ligand and the residues are depicted in stick-ball and stick style, respectively. The a1+ and b3subunits are depicted in ribbon style and are colored yellow and red, respectively.

a1b3 GABA A Receptor-Pyrazoloquinolinones Binding Hypothesis

Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 561834 BM I in a1+/b3-( Figure 8A ) shows a qualitatively similar binding orientation to the PQ scaffold as in the a1+/g2site. In both orientations, the quinoline ring is located underneath loop C and shows hydrophobic and/or pi-pi interactions interaction with a1Y209, a1F99, and b3Y62 or g2F77, respectively ( Table 3) . In contrast to the a1+/g2site, the quinoline nitrogen in a1+/b3does not display hydrogen bond interaction with the backbone of a1Y159. The altered steric and electrostatic pocket requirements shaped by b3Q64 and b3D43 might push the quinoline scaffold in a position that impedes the quinoline a1Y159 interaction in the a1+/b3site. The significant difference in the PQ interaction profile between the a1+/b3and the a1+/g2site is understood by the orientation of the pending phenyl moiety. While, the moiety is placed disfavorably in the a1 +/b3-site close to the acidic b3D43 residue, it shows favorable hydrophobic interactions with the equivalent residue g2Y58 in the g2 subunit. The absence of crucial interactions in the a1+/b3in comparison to the a1+/g2interface aligns with the experimental finding of 4 log potency differences in the two subunits.

We further compared BM I and BM II of 14 at the a1+/b3site with the cryo-EM structure of human a1b2g2 GABA A receptor (PDB ID: 6D6U) (Zhu et al., 2018) complexed with flumazenil (Ro15-1788) at the benzodiazepine site (a1+/g2-). In the solved structure, the imidazobenzodiazepine ring of flumazenil is oriented parallel to loop C, with fluorine at the 7 th position and carboxylate group at the 3 ' position is accepting a hydrogen bond from the side chain of a1H102 and g2T142, respectively ( Figure  8D ). The terminal ethyl group is extending toward the solvent between the tip of loop C and loop F. The imidazobenzodiazepine ring is involved in two p-p interactions involving residues a1Y210 and g2F77. The residues a1Y159, g2Y58, and g2A79 are further contributing to the binding of flumazenil via favorable hydrophobic interactions ( Figure 8D ). We then superposed BM I to the binding orientation of flumazenil ( Figure S11 ). The alignment revealed that the PQ ring is overlapping with the imidazobenzodiazepine ring of flumazenil. Whereas the pending phenyl ring of 14 and the terminal ethyl group of flumazenil are oriented away from each other and are solvent-exposed at both interfaces ( Figure S11) . Interestingly, the halogen atoms, Cl and F, in both structures are pointing toward the hydrophobic region of the a1+ subunit. The distance between the center of mass (COM) of the two ligands is 0.84 Å, indicating high commonality in the binding orientation, but with different binding strengths, at the two homologous sites of the GABA A receptor. While in the case of BM II, the distance between the COM of the ligands, 14 and flumazenil, is 1.81 Å ( Figure S12 ), indicating that BM II differs from the binding orientation of flumazenil. Also, due to the flipping of the fused ring in BM II, the quinoline nitrogen is occupying a position equivalent to the fluorine of flumazenil, which is in contradiction to BM I-flumazenil superposition, where the two halogen atoms are overlapping with each other. Based on the analysis of two distinct BMs with the flumazenil structure, it can be inferred that BM I is indeed more reliable than BM II to account for the binding of PQs. This set of results is further consistent with the new structures of the a1b3g2 subtype complexed with diazepam or alprazolam at the a1+/g2site, in which we observe a tight ligand volume overlap and a common interaction profile hallmarked by the ligand interactions with the residues a1H101, a1Y209, and a1Y159. In summary, the recent structures strengthen the BM I-like PQ binding orientation at the a1+/b3site.

Siebert et al. reported a 40-fold increase in potency of CGS-9895 (4) in the a1b3Q64A mutant (Siebert et al., 2018a) . At first sight, this is inconsistent with BM I in which b3Q64 acts as a hydrogen bond donor to the carbonyl-oxygen of the PQ scaffold, and the mutation would lead to the abolishment of this interaction. On the other hand, we observed that the large b3Q64 residue is pushing the PQ-scaffold away from a high affinity a1+/g2orientation. To computationally assess the effect of the mutant on our BM I orientation (p53), we converted the b3Q64 residue to its gamma analog alanine in the binding pose of 4 and 14 and then conducted in-situ ligand minimization followed by binding free energy calculations. The geometry optimization was performed using the OPLS-2005 force field and the Truncated Newton Conjugate Gradient (TNCG) minimization algorithm (see Methods). The RMSD of the poses of 4 and 14 between the wild-type and the mutant protein was 1.5 and 1.48 Å, respectively, indicating a considerable change in the binding orientation after optimization. Interestingly, the mutation from b3Q64 to its gamma analog and subsequent energy minimization resulted in a ligand orientation that displays a more "a1g2"-like interaction, i.e., two p-p interactions of the quinoline ring with a1Y209 and a1H101 and one backbone hydrogen bond of the quinoline nitrogen with a1Y159 ( Figure 8E and Figure S13) . Also, the binding energy of the optimized poses in the a1b3Q64A mutant was higher as compared to the a1b3Q64 wild-type pose. We reason that the mutation of b3Q64 to alanine increases the ligand-binding surface area that allows the ligand to readapt in an orientation where it can engage in favorable interactions with the binding site residues. Overall, the results obtained here are consistent with the experimental findings of the increased potency of 4 in the a1b3Q64A mutant.

The amino acid residues at both a1+/b1and a1+/b3interfaces are highly conserved and only show differences in position 41 and 180 of the b3 subunit ( Figure S14 ). The residue b3N41 at the a1+/b3correspond to b1R41 at the a1+/b1-, whereas b3R180 at the a1+/b3is equivalent to b1K180 at the a1+/b1-. Despite these small differences in the pocket, the pEC 50 of 14 is approximately 30 times higher in the a1+/b1compared to the a1+/b3interface (Simeone et al., 2017) . To analyze this experimental finding in the context of our BM I pose (p53), we performed molecular docking of 14 at the a1+/b1site using an a1b1g2 GABA A homology model (Figures S1 and S15) and generated 100 docking poses ( Figure S16 ). From the optimized docking poses of 14, we calculated the RMSD difference to the best performing a1+/b3-BM I pose (p53). This led to the identification of a docking pose that exhibited minimum RMSD with p53 (2.2 Å) and showed higher binding energy compared to BM I in a1b3 ( Figure 8F ). In addition, this pose displayed a good overlap with the binding mode reported by Siebert et al. (2018b) and the new GABA A structures. In the docking pose, the quinoline ring is engaged in two p-p interactions involving residues a1Y209 and a1H101, and the quinoline nitrogen atom is donating a hydrogen bond to the backbone of a1Y159 ( Figure 8F ). In addition, the pyrazolone ring (ring C) is engaged in two hydrogen bond interactions with the side chain of the residues a1S204 and b1Q64. The residues a1F99 and b1Y62 are additionally mediating the binding of the ligand through hydrophobic interactions. Analogously to the a1 +/b3-interface, the pending phenyl ring is located unfavorably close to b1D43 and is solvent-exposed. However, the negative effects of the charged b1D43 are likely diminished by a saltbridge with the aforementioned b1R41 residue. Overall, the results achieved are consistent with the increased biological activity of PZ-II-028 for the a1b1 subtype.

The identification of a ligand-receptor complex can significantly assist drug design programs through iterative multiparameter ligand optimization steps. However, the experimental structural elucidation of protein-ligand complexes is a multifaceted and time-consuming process, and it is often unfeasible for many membrane-bound protein targets. Here, homology modeling of a target protein in combination with molecular docking serves as an essential computational tool that can generate reasonable binding hypotheses (Miteva et al., 2005; Villoutreix et al., 2013; Ishoey et al., 2018; Lagarde et al., 2019; Singh et al., 2019b) . PQs exerts modulatory effects similar to benzodiazepines via the extracellular a1+/b1or a1+/b3ligand-binding site of the GABA A receptors. However, the molecular basis of interaction at the a+/binterface has remained elusive so far. To strengthen the reliability of the selection of a docking pose for the prediction of binding hypothesis, we herein developed an automatized routine that was applied to a set of molecules exhibiting a distinct SAR for the a1+/b3subtype of the GABA A receptor. We first docked a potent PQ 14 compound into the a1+/b3pocket and generated 100 diverse docking poses. To evaluate these different binding orientations, we derived protein-ligand complexes, via substituent placements, for 18 other PQs, 1-13 and 15-19, using the coordinates of each docking pose of 14. This was followed by MM-GBSA refinement to optimize the derivatized complexes and determine the protein-ligand binding energy. Subsequently, the optimized protein-ligand complexes were quantitatively evaluated by means of R SAR score between the predicted binding energy and biological activity data to assess the congruence between the analog placement and the PQ-SAR.

Our SAR guided docking pose estimation led to the identification of one favorable binding mode (BM I, p53) ( Figure 8A ) that is harmonious with the PQ-SAR as reflected by a maximum negative R SAR score of -0.83 and a maximum r 2 of 0.67. Also, BM I showed a low average and maximum RMSD of 0.75 Å and 2.45 Å to the reference pose, indicating a minimum disparity in the binding orientation among the PQ analogs poses. To evaluate the 40-fold increase in potency of 4 in the a1b3Q64A mutant (Siebert et al., 2018a) , we performed an insitu ligand minimization of BM I of 4 with b3Q64 mutated to alanine followed by binding free energy calculations. The optimized BM I revealed two p-p interactions with the residues a1H101 and a1Y209, and a backbone hydrogen bond interaction with the residue a1Y159, that might elucidate the high potency of 4 in the mutant. Importantly, these were the same set of interactions that were previously described by at the a1+/g2interface (Siebert et al., 2018b) indicating strong coherence between the two BMs at the homologous ligand binding interfaces. In addition, BM I showed good overlap to the binding orientation of flumazenil at the a1 +/g2-interface of the a1b2g2 GABA A receptor further signifying the reliability of BM I. A second, moderately performing binding mode, BM II, pose 66, (R SAR score: -0.79, r 2 : 0.61) ( Figure 8B ) was also identified that showed a high average and maximum RMSD of 1.02 and 3.22 Å to the reference pose indicating greater variability in the orientation of the poses. Furthermore, BM II showed poor overlap with the binding mode reported by Siebert et al. and the flumazenil structure indicating that, indeed, BM I is more promising than BM II to account for the binding of PQs at the a1+/b3interface.

Taken together, our docking protocol led to the detection of one convincing binding mode (BM I), providing a structural rationale for the PQ-SAR (Table 1) in a1b3. In BM I, the fused ring system show hydrophobic interactions with a1Y159, a1F99, b3Y62, and b3M115, while the pending phenyl ring D is extending toward the solvent, which is consistent with the findings of Varagic et al. (2013b) . The ring C is involved in a strong hydrogen bond interaction with b3Q64 that appears to be the main force driving the affinity apart from the contributions through hydrophobic interactions ( Figure 8A) . Notably, BM I showed the absence of backbone hydrogen bond interaction of the quinoline nitrogen which seems to be an essential interaction to gain affinity as suggested by Siebert et al. (2018b) In combination with the loss of backbone interaction and diminished hydrophobic interactions, this altogether explains the overall low affinity of PQs at the a1+/b3interface in comparison to the a1+/g2interface. Importantly, b3D43 is revealed as a crucial residue hindering the binding of PQs at the a1+/b3interface due to the electrostatic repulsion between the carboxyl group of D43 and the electron-rich areas of the ligand. The presence of strong electron-withdrawing groups at the R ' 4 position in PQs, 16, 17, and 19, seems to reduce the electron density over the ring D, thus decreasing the degree of the electrostatic clash with b3D43. Additionally, these PQs are enabled with a lipophilic group at the R 8 position resulting in strong interaction with the hydrophobic subpocket. This might explain their high affinity compared to the reduced activity of PQs 1-6 and moderate activity of PQs 7-15, which have either strong or moderately activating groups substituted at the R ' 4 position. The importance of b3Q64 for PQ binding was revealed in the b3Q64A mutant, which led to a 40-fold increase in potency for 4. Our in silico mutagenesis and energy calculations showed that the mutation of b3Q64 to alanine results in the increase of binding surface area that allows the ligand to accommodate in an energetically favorable orientation, which might explain the high affinity of compound 4 in the mutant protein. The optimized mutant pose and associated interactions were found to be in good agreement with the binding features described by Siebert et al. (2018b) , which reinforces the reliability of BM 1. The high affinity of PQs for the a1b1 subtype compared to a1b3 can be explained by the presence of a positively charged residue b1R41 that allows for electrostatic interactions such as p-p or a cation-p interaction with the ring D of the ligand and possible reduction in electrostatic repulsion via a salt-bridge interaction with b1D43. Whereas in the a1b3 subtype, no such interactions were observed that have a neutral N41 in the same position. Also, the docking pose in a1b1 shows a conserved hydrogen bond interaction of the quinoline nitrogen with the backbone of a1Y159 and two p-p interactions involving a1H101 and a1Y209, that is, consistent with the findings reported by Siebert et al., (2018b) . Despite the good agreement of BM I with the previous studies and the recent GABA A structures, there is a need for structures with ligand bound to the a+/bsite in order to understand the binding orientation better. Moreover, this would allow benchmarking of docking studies against these structures, which definitely would increase the validity of the binding hypotheses retrieved.

However, next to SAR availability, the applicability of our protocol strongly depends on the characteristics and the quality of the underlying SAR. Incongruent SAR patterns, as well as an inadequate SAR-hypersurface, may be considered as limiting factors that impede the proposed approach. For example, a flat SAR without any discontinuity would not carry any discriminative potential for pose prioritization (Siebert et al., 2018b) . Here, the calculation of the R SAR scores might provide a quick suitability assessment. In terms of target space, we believe that due to the rigorousness of the post-docking derivatization and subsequent SAR congruency assessments, our protocol might be more applicable to proteins accommodating rather tight and narrow binding pockets. Hence, in addition to R SAR calculations, B-factors analysis (Vihinen et al., 1994) , binding site analysis, and techniques to assess protein flexibility such as molecular dynamics (MD) simulations may provide estimates for the suitability of our protocol at a given context.

The improvement over the previously reported SAR-Scoring approach (Siebert et al., 2018b) is energy minimization, which allows the energy-based tuning and mutual adaptation of the receptor-ligand complex. The minimized protein-ligand complexes are energetically more favorable compared to the native unrefined complexes owing to the elimination of probable steric clashes and close contacts of the substituents with the protein residues that originated after derivatization. However, the current approach also comes with the limitation that it currently minimizes the complex into the next local minimum necessitating further enhancement. Here, quantum mechanicsmolecular mechanics (QM-MM) optimization of the docking poses could be considered as a methodological advancement to the current approach that might offer global minimum orientations of the ligand and the neighboring interacting residues. Also, the derivatized poses can alternatively be refined using short MD simulations to improve the quality of the poses. This can be followed by rescoring of a pool of binding conformations to filter the best results. Then, the best-ranked poses exhibiting a similar orientation can be used for the SAR congruency calculations to identify the promising hypotheses. Overall, the findings attained here may be useful for designing critical experiments that might help to establish the role of individual amino acids, for instance, b3D43 in the ligand binding.

In summary, we showcased here a structure-based strategy that increases the reliability of binding mode prediction for targets for which no experimental structure is available. We demonstrated this by applying an automatized routine to a set of molecules for which a distinct SAR is available. The proposed approach incorporates a rigorous sampling of docking poses, binding free energy calculations, and a quantitative assessment of the poses with respect to the biological activity data of the molecules. Importantly, by applying this protocol, we have corroborated computational predictions with PQ-SAR data and experimental mutagenesis study and have uncovered a common residue interaction profile of the ligands at the a1+/b3site. The knowledge gained from this study combined with the availability of the cryo-EM structures of the a1b3g2 and a1b2g2 subtypes of GABA A receptors will reinvigorate the detailed investigations of the binding modes and the discovery of novel small molecule modulators targeting the much-uncharted a+/binterface using structure-and experimental-based approaches. Finally, our methodology for the binding mode prediction can be extended to therapeutically relevant protein targets for which sufficient SAR data is available, such as G protein-coupled receptors, proteases, or kinases.

The high-resolution X-ray structure (2.97 Å) of the human GABA A b3 homopentamer (PDB ID: 4COF) (Miller and Aricescu, 2014) served as the template for building the human protein homology models of the a1b3g2 and a1b1g2 subtypes. One hundred homology models per subtype were constructed using MODELLER 9.14 (Sali and Blundell, 1993) . We used the previously reported sequence alignment for building the models (Puthenkalam et al., 2016) . The top-scoring model, with respect to the DOPE score (Shen and Sali, 2006; Singh, 2016, p. 5) , was selected for the docking studies. The model was subjected to automated structure preparation using the Protein Preparation Wizard (Schrodinger Suite 2015 , 2015 in the Schrödinger Suite in order to optimize the hydrogen bonding network, and enable proper protonation of titratable residues and optimal selection of the Asn, Gln, and His side-chain orientation. Finally, the structure was energy minimized by keeping the backbone constrained using the OPLS-2005 force field (Weiner et al., 1986) . The stereochemical quality of the top-ranked homology model was also evaluated via the assessment of a Ramachandran plot computed with PROCHECK (Laskowski et al., 1993; Laskowski et al., 2018) . The Verify 3D (Eisenberg et al., 1997) calculations were performed in Discovery Studio v. 4.0 (Dassault Systèmes BIOVIA, n.d). This tool assesses the compatibility of the 3D structure of a protein model with the sequence of residues it contains. The expected high scores are based on a statistical analysis of high-resolution structures in the PDB. The expected low score is 45% of the high score and is typical of grossly misfolded structures having this sequence length. If the model structure has a Verify score higher than the expected high score, the structure is likely to be correct. If the overall quality score is between the reference values, then some or all of the structure may be incorrect, and it requires closer scrutiny. If the overall quality is lower than the expected low score, then the structure is almost certainly misfolded. The chains A, B, and E of the model were deleted, and only the chain C and D were retained as they represent the extracellular a1b3 or a1b1 subunits.

The hydrophobicity profile of the models was computed using Discovery Studio v. 4.0 (Dassault Systèmes BIOVIA, n.d) by relying on the Kyte-Doolittle hydrophobicity scale (Kyte and Doolittle, 1982) . The adaptive Poisson Boltzmann Solver version 1.3 (APBS) (Baker et al., 2001) was used for generating the electrostatic potential surface (EPS), with PQR file generated from the PDB coordinates using PDB2PQR (Dolinsky et al., 2004; Dolinsky et al., 2007) (v. 2.0) and the AMBER forcefield (Sorin and Pande, 2005) utilizing PROPKA (Li et al., 2005) to determine the protonation state and radius of the individual atoms at pH 7.0. The pH-specific PQR file was subsequently used to calculate the electrostatic surface charge distribution with a Linearized Poisson-Boltzmann (PB) equation and cubic B-spline discretization of the charge distributions (Im et al., 1998) . PB calculations were performed at 298 K with a dielectric constant of 78.0 for water and 4.0 for the protein interior. The ion concentrations were set to 0.015 M with an ionic radius of 2.0 Å. Ion accessibility was defined using inflated van der Waals radii. The dielectric coefficient was defined using the molecular surface definition with simple harmonic average smoothing (Baker et al., 2001) . The resulting electrostatic surface was visualized by Chimera V. 1.11 (Pettersen et al., 2004) .

The SiteMap module of Schrödinger was used to analyze the binding site (Schrödinger Release 2015-1, 2015c). This tool investigates the binding pockets by using grid points, called site points, and then employs the van der Waals (vdW) and electrostatic interactions of a probe positioned at each point to create field maps. The probe simulates a water molecule with a vdW radius of 1.6 Å. SiteMap partitions the solvent accessible surface into three types of regions: hydrophobic, hydrophilic, and mixed character regions. The hydrophilic region is further divided into hydrogen bond donor, hydrogen bond acceptor, and metal-binding regions. The hydrogen bond donor and acceptor properties indicate the degree to which a ligand might be expected to donate and accept hydrogen bonds, respectively.

The 3D structure of the ligand 'PZ-II-28' 14 was built in Maestro and then minimized using the OPLS-2005 force field (Banks et al., 2005) . The molecular docking simulations of 14 into the active site of the a1b3 and a1b1 subtype were performed by using GOLD v.5.2.2 (Jones et al., 1997) . The putative binding pocket was defined by a cutoff distance of 11.5 Å around the residue a1S204 of the C-loop at both a1+/b3and a1+/b1-. Ten residues were selected with flexible side chains (b1R41/b3N41, b1/3D43, b1/3Y62, b1/3Q64, a1H101, a1Y159, a1S204, a1S205, a1T206, and a1Y209), and a soft potential was considered to increase the backbone flexibility of the C-loop residues a1S204, a1S205, a1T206, and a1G207. One hundred docking poses were collected from both sites to ensure convergence of conformational sampling. The docking pose of compound 4 and 14 in the mutant protein were minimized through TNCG (truncated Newton conjugate gradient) minimization algorithm (Zhu et al., 2007) with maximum iteration steps set to 2500 and with a convergence gradient of 0.05. The entire structure except for the ligand and the mutated residue was constrained by applying a force constant of 200 kcal/mol/Å 2 .

The "Interaction Fingerprints Panel" of Maestro was used for deriving the different molecular interactions between the binding site residues and the ligand in the docking poses as described previously (Deng et al., 2004; Singh et al., 2006) . This method describes the presence or absence of noncovalent interactions (hydrogen bond and hydrophobic interactions) between the ligand and the residues by using bits. In this study, a distance cutoff of 5 Å between heavy atoms was defined for the binding site, and the interacting set comprises the residues that contain atoms within the specified cutoff distance from the ligand atoms. An interaction matrix is then constructed, including the bits with appropriate information of the defined chemical interactions.

Post-docking derivatization was performed using the "r_groups_enumerate" utility of Schrödinger (Schrödinger Release 2015 -1, 2015 . This tool allows the addition and deletion of atoms over a given core molecular scaffold and sources for each of the R groups (analog substituents). Briefly, each analog substituent was defined by a structure file and with one or more attachment atoms defined by the core molecule atom indices. For each docking pose of compound 14 at the a1 +/b3-an array of derivatives of compounds 1-13 and 15-19 (Table 1 ) was constructed using the initial coordinates of the PQ 14 scaffold.

The cheminformatics tool "clustering of conformers" of schrödinger was used to compute the rmsd matrix of the 100 docking poses for compound 14. The matrix served as input for MDS to visualize the geometric similarity between poses. The MDS was conducted using the "canvasMDS" utility of Schrödinger (Schrödinger Release 2015-1, 2015a). The first two dimensions were used to visualize the pose space.

The molecular mechanics−generalized Born surface area (MM-GBSA) method was used to calculate the binding free energy and geometry optimization of the docking poses. The binding energy (DG bind ) can be expressed by equation 1, where G complex , G protein , and G ligand signifies the free energy of the complex, energy of the protein without the ligand and energy of the unbound ligand, respectively.

DG bind = G complex − (G protein − G ligand )

The calculations were performed using the Maestro GUI "Binding Energy Estimation" panel in Prime with the ligand and residues within 5 Å of the minimized ligand. The free energy of the complex, protein, or ligand is a sum of nonbonded electrostatic interactions, van der Waals, internal strain, and solvation energy terms. These parameters were calculated by using the VSGB2.0 implicit solvation model and OPLS-2005 (Li et al., 2011 Banks et al., 2005) . The entropic term associated with the protein or ligand is not considered by default. However, the solvent entropy term is implemented in the VSGB2.0 (Li et al., 2011) . The ligand in the unbound state is minimized in SGB solvent but is not otherwise sampled. In the calculation of the complex, the ligand is minimized in the context of the receptor. The residues within 5 Å of the ligand were minimized, while the rest of the protein is held fixed in all calculations. The protein and ligand optimization were limited to local energy minimization. The MM-GBSA energies were computed with and without the inclusion of ligand strain. The ligand strain energy is the difference between two energies: the energy of the ligand as it is in the complex and the energy of the extracted ligand, minimized, starting from the geometry in the refined complex.

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

NS performed the computational study and wrote the paper. BV reviewed the manuscript.

Electrostatics of nanosystems: application to microtubules and the ribosome

FastTargetPred: a program enabling the fast prediction of putative protein targets for input chemical databases

Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?

Dassault Systèmes BIOVIA (n.d)

The Pymol Molecular Graphics System

Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions

PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations

PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations

VERIFY3D: assessment of protein models with three-dimensional profiles

How well can the accuracy of comparative protein structure models be predicted?

Neurotransmitter-gated ion channels as unconventional allosteric proteins

The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities

Application of the three-dimensional structures of protein target molecules in structure-based drug design

Identifying and Characterizing Binding Sites and Assessing Druggability

Continuum solvation model: Computation of electrostatic forces from numerical solutions to the Poisson-Boltzmann equation

Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders

An in-depth structural view of a GABAA brain receptor

Development and validation of a genetic algorithm for flexible docking1

Similarity and Dissimilarity: A Medicinal Chemist's View

A simple method for displaying the hydropathic character of a protein

A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments

PROCHECK: a program to check the stereochemical quality of protein structures

PDBsum: Structural summaries of PDB entries

Cryo-EM structure of the human a1b3g2 GABAA receptor in a lipid bilayer

Very fast empirical prediction and rationalization of protein pKa values

The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling

In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening

A medicinal chemistry perspective on structure-based drug design and development

GABAA receptor signalling mechanisms revealed by structural pharmacology

Crystal structure of a human GABAA receptor

Unexpected Properties of d-Containing GABAA Receptors in Response to Ligands Interacting with the a+ b-Site

Fast Structure-Based Virtual Ligand Screening Combining FRED, DOCK, and Surflex

International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update

In silico Description of LAT1 Transport Mechanism at an Atomistic Level

UCSF Chimera-a visualization system for exploratory research and analysis

Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?

R: A language and environment for statistical computing

The GABAA receptor alpha+beta-interface: a novel target for subtype selective drugs

Refinement and Rescoring of Virtual Screening Results

Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands

y-Randomization and Its Variants in QSPR/QSAR

Comparative protein modelling by satisfaction of spatial restraints

High affinity central benzodiazepine receptor ligands. Part 2: quantitative structure-activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones

Glutamine transporters as pharmacological targets: From function to drug design

Modelling three-dimensional protein structures for applications in drug design

Canvas

Maestro, version

Schrödinger Release

Protein Preparation Wizard

Statistical potential for assessment and prediction of protein structures

Engineered flumazenil recognition site provides mechanistic insight governing benzodiazepine modulation in GABAA receptors

SAR-Guided Scoring Function and Mutational Validation Reveal the Binding Mode of CGS-8216 at the a1+/g2-Benzodiazepine Site

Allosteric modulation of GABAA receptors via multiple drugbinding sites

Mapping of the benzodiazepine recognition site on GABA(A) receptors

Molecular tools for GABAA receptors: High affinity ligands for b1-containing subtypes

Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1

Structural Interaction Fingerprints: A New Approach to Organizing, Mining, Analyzing, and Designing Protein-Small Molecule Complexes

Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods

Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1)

Fast rescoring protocols to improve the performance of structure-based virtual screening performed on proteinprotein interfaces

Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace

Structurebased drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages

Molecular Modelling of Human Multidrug Resistance Protein 5 (ABCC5)

The compromise of virtual screening and its impact on drug discovery

Exploring the Helix-Coil Transition via All-Atom Equilibrium Ensemble Simulations

Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description

Stoichiometry and assembly of a recombinant GABAA receptor subtype

Towards functional selectivity for a6b3g2 GABAA receptors: a series of novel pyrazoloquinolinones

Subtype selectivity of a+b-site ligands of GABAA receptors: identification of the first highly specific positive modulators at a6b2/3g2 receptors

Identification of novel positive allosteric modulators and null modulators at the GABAA receptor a+b-interface

Allosteric GABAA Receptor Modulators-A Review on the Most Recent Heterocyclic Chemotypes and Their Synthetic Accessibility

Improved protein-ligand docking using GOLD

Accuracy of protein flexibility predictions

One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade

The structural basis for agonist and partial agonist action on a b(1)-adrenergic receptor

An all atom force field for simulations of proteins and nucleic acids

Rescoring of docking poses under Occam's Razor: are there simpler solutions?

Multiscale Optimization of a Truncated Newton Minimization Algorithm and Application to Proteins and Protein-Ligand Complexes

Structure of a human synaptic GABA A receptor

This work was partly performed with funding from FWF project P27746 to Margot Ernst, Michael Schnürch, and Gerhard F. Ecker. NS is grateful to Lars Richter, Margot Ernst, and Gerhard F. Ecker for their valuable intellectual inputs in this project. We thank the Reǵion Hauts-de-France, University of Lille, INSERM Institute for financial supports. We also thank the editors and reviewers for their helpful comments, which much improved the manuscript.

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2020. 561834/full#supplementary-material